Robust Protective Effect of COVID-19 Vaccination in India—Results of Survey in the Midst of Pandemic’s Second Wave

Author:

Parikh Purvish M.1,Maheshwari Udip2,Krishna V. M.3,Gupta S.4,Patil T.5,Mandhaniya S.6,Mehta P.7,Somashekhar S. P.8,Parekh B.9,Singh R.10

Affiliation:

1. Mumbai Oncocare Centers, Mumbai, Maharashtra, India

2. Department of Medical Oncology, Mumbai Oncocare Centers, Mumbai, Maharashtra, India

3. Institute of Oncology AIG Hospitals Gachibowli, Hyderabad, Telangana, India

4. Department of Medical Oncology & Hemato Oncology, Max Super Speciality Hospital, Mohali, Punjab, India

5. Department of Medical Oncology, Sahyadri Hospital, Pune, Maharashtra, India

6. Department of Medical Oncology, Mandhanya Cancer Hospital & Research Center, Nagpur, Maharashtra, India

7. Department of Medical Oncology/Hematoncology/BMT, Asian Institute of Medical Sciences, Faridabad, Haryana, India

8. Manipal Comprehensive Cancer Center, Manipal Hospital, Bengaluru, Karnataka, India

9. Department of Oncology, Shalby Cancer & Research Institute, Ahmedabad, Gujarat, India

10. Department of Medical Oncology, Narayana Health, Delhi NCR, India

Abstract

Abstract Introduction Our objective was to document the incidence of COVID-19 in vaccinated health care professionals and related personnel. Method We conducted an online survey to ascertain the incidence of COVID-19 symptoms, reverse transcriptase polymerase chain reaction (RT-PCR) positivity, effect on normal activity, need for anti-COVID-19 medication, hospitalization, and death among individuals who had completed both doses of COVID vaccination at least 2 weeks earlier. Results A total of 351 unique valid responses were received. Among the 340 people who had been vaccinated in India, 5% (17/340) had COVID-19 symptoms, 4.7% (16) became COVID-19 RT-PCR positive, 12 (3.5%) had sickness preventing normal daily activity, 2.65% (9) required anti-COVID-19 medication, and 1.18% (4) required hospitalization. Among family members living with the survey responders, the corresponding incidence was even lower. There was one death in this group. Discussion Being health care professionals, the responders would be at higher risk of daily exposure to COVID-19. Even in this high risk group, the vaccine efficacy is good. Vulture journalists should stop spreading fake news and misinformation that makes people hesitate taking the vaccine or be afflicted analysis paralysis. Every person who chooses to remain unvaccinated increases the risk for our entire community. We also need to follow universal precautions (wearing mask, physical distancing, handwashing) diligently without letting down our guard.

Publisher

Georg Thieme Verlag KG

Subject

Cancer Research,Oncology

Reference6 articles.

1. Resurgence of COVID-19 in India - Challegnges and Solutions;P M Parikh;Int J Med Sci,2021

2. Social media and vaccine hesitancy: new updates for the era of COVID-19 and globalized infectious diseases;N Puri;Hum Vaccin Immunother,2020

3. Hot race for COVID-19 vaccines - Light at the end of the tunnel just got brighter;P Parikh;Int J Mol Immuno Oncol,2021

4. Lessons from the COVID-19 pandemic for virtual academic activities;P Parikh;Indian J Med Sci,2020

5. Transition to LPG for cooking: a case study from two states of India;A Sharma;Energy Sustain Dev,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3